Twist Bioscience Corp reports results for the quarter ended June 30 - Earnings Summary
18/11/2024 14:31
* Twist Bioscience Corp TWST.OQ reported a quarterly
adjusted
loss of $1.47 per share for the quarter ended June 30, higher
than the same quarter last year, when the company reported EPS
of -78 cents. The mean expectation of eleven analysts for the
quarter was for a loss of 71 cents per share. Wall Street
expected results to range from -75 cents to -67 cents per share.
* Revenue rose 21.7% to $81.46 million from a year ago;
analysts
expected $82.20 million.
* Twist Bioscience Corp's reported EPS for the quarter was a
loss
of 59 cents.
* The company reported a quarterly loss of $34.66 million.
* Twist Bioscience Corp shares had fallen by 18.3% this
quarter and gained 0.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 1.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Twist Bioscience
Corp is $54.00
This summary was machine generated from LSEG data November 18 at
02:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.71 -1.47 Missed
Jun. 30 2024 -0.77 -1.47 Missed
Mar. 31 2024 -0.82 -0.79 Beat
Sep. 30 2023 -0.92 -0.75 Beat